The Use of Magnetic Resonance Imaging in the Prostate Cancer Primary Diagnostic Pathway: Is It Ready for Primetime?.

Author: Niranjan J SATHIANATHEN ¹ ; Christopher A WARLICK
Author Information

1. Department of Urology, University of Minnesota Medical School, Minneapolis, MN, USA. nsathian@umn.edu
Publication Type:Review
Keywords: Biopsy; Diagnosis; Magnetic resonance imaging; Prostate cancer; Prostatic neoplasms
MeSH: Biopsy; Diagnosis; Humans; Magnetic Resonance Imaging*; Male; Prostate*; Prostatic Neoplasms*
From:The World Journal of Men's Health 2018;36(3):223-229
CountryRepublic of Korea
Language:English
Abstract: Multiparametric magnetic resonance imaging (mpMRI) has been increasingly utilized in the prostate cancer diagnostic landscape over the last five years. The majority of the literature has focused on its use in men with a previous negative biopsy. However, over time, clinicians have begun using mpMRI in the work-up of men being considered for primary biopsy and subsequently data characterizing its diagnostic performance in this setting is emerging. This review comprehensively assesses the utility of mpMRI in the primary biopsy setting.